Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to ...

Trinity Health’s hospitals in Muskegon and Grand Rapids are the first in West Michigan to offer the Inspire implant to patients with moderate to severe obstructive sleep apnea.

After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...

Advanced ENT & Allergy welcomes Dr. Elizabeth Wadsworth to Atlanta, offering expert ENT and Inspire® sleep apnea care.

A new implantable device provides an alternative treatment for sleep apnea, offering relief to those who struggle with ...

Nyxoah announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

Barrett received what his mother calls a miracle on June 19 at Oishei Children’s Hospital where a University at Buffalo team implanted in Barrett’s chest a 2-by-2 inch device that makes quality sleep ...

Obstructive Sleep Apnea (OSA) is more than a nighttime nuisance, it is a silent global health challenge. The Lancet ...

GAAP revenue for Q2 2025 rose to $217.1 million, up 11% from the prior year and beating expectations. Management reduced full-year 2025 revenue and diluted net income per share guidance due to a ...

Inspire Medical (NYSE: INSP) announced today that its board of directors authorized the repurchase of up to $200 million in common stock.

The Summers Value Fund LP returned -1.8% net1 in Q2 2025, trailing the Russell 2000 Index ETF, which returned 8.5%, and the ...